Новости за 05.11.2024

WE League 2024/2025 - Matchday 7 - Played 02-Nov-24 - Posted by sedor18

-

Stephen Luby and Jenna Forsyth have spent years examining the widespread presence of lead, including in some commonly consumed products. They discuss the prevalence of lead and share insights on food safety policies, education, and lead-free alternatives.

The academic holiday was founded in 2021 by Sean Casey, ’22, and Jonathan Lipman, ’22, with the goal of engaging students in the democratic process.

This randomized study uses electronic health record data to investigate how a monthly cash benefit delivered to low-income individuals affects emergency department and outpatient care utilization in a low-income US city.

This Viewpoint examines the implementation of the Sergeant First Class Heath Robinson Honoring Our Promise to Address Comprehensive Toxics Act, known as the PACT Act, which expanded health care for millions of veterans from any era exposed to toxic hazards.

This Viewpoint discusses the spread of medetomidine in the US illicit opioid market and the need for monitoring and a public health response.

This Viewpoint discusses the challenges to implementing artificial intelligence–based translation in clinical settings and what health care organizations can do to mitigate these challenges.

This noninferiority randomized clinical trial investigates whether tenecteplase is noninferior to alteplase for the treatment of Chinese patients with acute ischemic stroke eligible for intravenous thrombolysis within 4.5 hours after symptom onset.

In September 2023, we announced the 10th International Congress on Peer Review and Scientific Publication, to be held in Chicago, Illinois, on September 3-5, 2025. We now officially call for abstract submissions.

This Viewpoint examines how the outcome of the 2024 US presidential election could affect the future of medicine and public health, particularly the antimedicine proposals found in the Republican Party’s Project 2025 playbook.

This narrative review summarizes current evidence on the epidemiology, pathophysiology, diagnosis, and treatment of chronic spontaneous urticaria.

In Reply We appreciate Mr Meng and colleagues’ keen interest in our publication, in which we demonstrated that among individuals with clinical knee OA experiencing significant knee pain and effusion-synovitis on magnetic resonance imaging (MRI), daily supplementation with 2 g of krill oil did not improve knee pain over 24 weeks compared with placebo. Meng and colleagues raise several points, which we address in this reply.

To the Editor Dr Laslett and colleagues recently reported that daily supplementation with 2 g of krill oil in patients with knee osteoarthritis (OA) and effusion-synovitis did not alleviate knee pain over a 24-week period compared with placebo. We have several concerns about this randomized clinical trial.

In Reply In response to Dr Xu and colleagues, we performed additional analyses to examine the difference in clinical benefit of RAS blockers between Black and White patients (Table). The results were nearly identical to the findings in our main analysis comparing Black and non-Black patients, suggesting the heterogeneity across these patient groups was not substantial, as Xu and colleagues had expected.

To the Editor A recent article evaluated the efficacy of renin-angiotensin system (RAS) blockade in patients with heart failure by race, using both 1-stage and 2-stage meta-analyses, dose-response analyses, and cumulative hazard estimates. However, we have several concerns about racial classifications, Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessments, and the credibility of the reported subgroup effects.

This study uses public US Food and Drug Administration lists to identify new drugs approved from 2015 through 2021 to examine recent estimates of compliance with and timing of pediatric testing requirements after passage of the Pediatric Research Equity Act.

This Medical News story is an interview about the US Department of Veterans Affairs’ pioneering work in using artificial intelligence to improve patient care.

The application of artificial intelligence (AI) to address challenges in health care is almost universally described as transformative. Acknowledging the rapid pace at which tools incorporating AI have advanced toward clinical practice, prior JAMA editorials noted the importance of ensuring the rigorous evaluation of approaches using AI at every stage of development. It emphasized the JAMA Network’s commitment to apply the same standards and principles that would be expected for any other new technology.

It’s said that at the moment of death, our ancestors will appear at the foot of the bed, beckoning. We will be blinded by the light, squinting to see the transfigured faces of those waiting for us in heaven as we gasp our final inhalation.

In Reply We appreciate the Letter and perspective shared by Drs Davis and Lorig in response to our Editorial on the role of lifestyle interventions for obesity in the era of glucagon-like peptide-1 receptor agonists. Although the authors agree with our perspective that there should be multiple strategies for addressing obesity, they call into question the premise that pharmacologic and surgical treatments for obesity are superior to behavioral treatments.

To the Editor We agree with many points made by Dr Ard and colleagues in a recent Editorial. Weight loss is indeed challenging for many people with excess weight. Long-term weight maintenance is difficult to attain, particularly when treatment is withdrawn. However, we challenge the implication that drug and surgical treatments are superior to behavioral treatment. The authors note numerous conflicts of interest in these industries.

This JAMA Insights in the Women’s Health series discusses the first over-the-counter progestin-only oral contraceptive available in the US, including its effectiveness, mechanism of action, and accessibility.

In this narrative medicine essay, an internal medicine physician reflects on her intentional and visible efforts to model for young physicians the balance between career and parenthood.

This JAMA Patient Page describes cannabinoid hyperemesis syndrome, a gastrointestinal condition associated with frequent and long-term use of cannabis.